Brief: Moberg Pharma Q1 EBITDA Loss Narrows To SEK 4.8 Million

Moberg Pharma AB (publ)

10/05/2022 07:10

May 10 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * MOBERG PHARMA'S INTERIM REPORT JANUARY - MARCH 2022
    * Q1 EBITDA SEK -4.8 MILLION (-5.4)
    * Q1 OPERATING PROFIT (EBIT) SEK -5.4 MILLION (-6.1)
    * Q1 PROFIT AFTER TAX SEK -4.4 MILLION (-5.0)

Source text for Eikon:  ID:nWkr8h9PL2 
Further company coverage:  MBPH.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))